These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 37565424)
1. Design and investigation of targeting agent orientation and density on nanoparticles for enhancing cellular uptake efficiency. Fei W; Wang X; Guo J; Wang C J Mater Chem B; 2023 Aug; 11(34):8228-8240. PubMed ID: 37565424 [TBL] [Abstract][Full Text] [Related]
2. Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles. Xu Y; Wu H; Huang J; Qian W; Martinson DE; Ji B; Li Y; Wang YA; Yang L; Mao H Theranostics; 2020; 10(6):2479-2494. PubMed ID: 32194814 [No Abstract] [Full Text] [Related]
3. Improving the systemic drug delivery efficacy of nanoparticles using a transferrin variant for targeting. Chiu RY; Tsuji T; Wang SJ; Wang J; Liu CT; Kamei DT J Control Release; 2014 Apr; 180():33-41. PubMed ID: 24524898 [TBL] [Abstract][Full Text] [Related]
4. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
5. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin. Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909 [TBL] [Abstract][Full Text] [Related]
6. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform. Hou L; Shan X; Hao L; Feng Q; Zhang Z Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767 [TBL] [Abstract][Full Text] [Related]
7. Robust Strategy for Antibody-Polymer-Drug Conjugation: Significance of Conjugating Orientation and Linker Charge on Targeting Ability. Wan J; Li Y; Jin K; Guo J; Xu J; Wang C ACS Appl Mater Interfaces; 2020 May; 12(21):23717-23725. PubMed ID: 32368886 [TBL] [Abstract][Full Text] [Related]
8. Transferrin conjugated poly (γ-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery. Zhao C; Liu X; Liu J; Yang Z; Rong X; Li M; Liang X; Wu Y Colloids Surf B Biointerfaces; 2014 Nov; 123():787-96. PubMed ID: 25454663 [TBL] [Abstract][Full Text] [Related]
9. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier. Gan CW; Feng SS Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685 [TBL] [Abstract][Full Text] [Related]
10. The effects of ligand valency and density on the targeting ability of multivalent nanoparticles based on negatively charged chitosan nanoparticles. Cao J; Zhang Y; Wu Y; Wu J; Wang W; Wu Q; Yuan Z Colloids Surf B Biointerfaces; 2018 Jan; 161():508-518. PubMed ID: 29128837 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional Polyethylene Glycol (PEG)-Poly (Lactic-Co-Glycolic Acid) (PLGA)-Based Nanoparticles Loading Doxorubicin and Tetrahydrocurcumin for Combined Chemoradiotherapy of Glioma. Zhang X; Zhao L; Zhai G; Ji J; Liu A Med Sci Monit; 2019 Dec; 25():9737-9751. PubMed ID: 31856143 [TBL] [Abstract][Full Text] [Related]
12. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT. Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819 [TBL] [Abstract][Full Text] [Related]
14. Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins. Gabold B; Adams F; Brameyer S; Jung K; Ried CL; Merdan T; Merkel OM Drug Deliv Transl Res; 2023 Mar; 13(3):822-838. PubMed ID: 36207657 [TBL] [Abstract][Full Text] [Related]
15. Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood-brain barrier. Yan F; Wang Y; He S; Ku S; Gu W; Ye L J Mater Sci Mater Med; 2013 Oct; 24(10):2371-9. PubMed ID: 23793566 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775 [TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Li X; Ding L; Xu Y; Wang Y; Ping Q Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296 [TBL] [Abstract][Full Text] [Related]
18. Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles. Zhu Y; Zhang W; Chen J Drug Des Devel Ther; 2023; 17():1-13. PubMed ID: 36636745 [TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy. Amreddy N; Muralidharan R; Babu A; Mehta M; Johnson EV; Zhao YD; Munshi A; Ramesh R Int J Nanomedicine; 2015; 10():6773-88. PubMed ID: 26604751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]